Advisory board
CYLCOMED’s Advisory Board has four renowned experts from a variety of organisations and research institutions, all active players in related areas who have agreed to contribute their time. The AB offers support on state-of-the-art analyses as valuable inputs for EC policy impacts and future priorities and provides recommendations on the current European landscape.
Initial Advisory Board members are:
![Antonio_Kung](http://www.cylcomed.eu/wp-content/uploads/sites/88/2023/03/Antonio_Kung.png)
Antonio Kung
Co-founder, Trialog
![ALESSIA](http://www.cylcomed.eu/wp-content/uploads/sites/88/2023/03/ALESSIA-MODIFICATA-1024x1024-1-1024x1024.jpg)
Alessia Moltani
CEO of Comftech S.r.l
![Stefano-Finazzi](http://www.cylcomed.eu/wp-content/uploads/sites/88/2023/03/Stefano-Finazzi-2.jpg)
Stefano Finazzi
Laboratory of Clinical Data Science, Farmacological R. I. Mario Negri
![Sebastien-Ziegler](http://www.cylcomed.eu/wp-content/uploads/sites/88/2023/03/Sebastien-Ziegler-400x400-1.jpg)